μ-, δ- and κ-opioid receptor agonists do not alter the discriminative stimulus effects of cocaine or d-amphetamine in rats

Drug and Alcohol Dependence

Volumn 48, Issue 3, 1997, Pages 209-220

  Woolfolk, D R ^a   Holtzman, S G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Cocaine; Drug discrimination; Opioid agonists

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BREMAZOCINE; BUPRENORPHINE; COCAINE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DEXAMPHETAMINE; DIAMORPHINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ETICLOPRIDE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; METHADONE; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; N (1 CARBOXY 2 PHENYLETHYL)PHENYLALANYL BETA ALANINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALBUPHINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; INTRACISTERNAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TRAINING;

ANALYSIS OF VARIANCE; ANIMALS; COCAINE; CONFIDENCE INTERVALS; CUES; DEXTROAMPHETAMINE; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INDIVIDUALITY; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID;

ANIMALIA;

EID: 0030834623     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(97)00129-4     Document Type: Article

References (56)

1. Appel, J., Weathersby, R., Cunningham, K., Callahan, P., Barrett, R., 1988. Stimulus properties of dopaminergic drugs: Comparisons involving selective agonists and antagonists. In: Colpaert, F., Balster B.L. (Eds.), Transduction Mechanisms of Drug Stimuli, Psychopharmacology Series 4. Springer-Verlag, Berlin, pp. 44-56.
2. Arnold E.B., Molinoff P.B., Rutledge C.O. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamines. J. Pharmacol. Exp. Ther. 202:1977;544-547.
3. Barrett R., Appel J. Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine. Psychopharmacology. 99:1989;13-16.
4. Bilsky E.J., Montegut M.J., Delong C.L., Reid L.D. Opioidergic modulation of cocaine conditioned place preferences. Life Sci. 50:1992;PL85-PL90.
5. Bourgoin S., Le Bars D., Artaud F., Clot A.M., Bouboutou R., Fournie-Zaluski M.C., Roques B.P., Hamon M., Cesselin F. Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release for met-enkephalin- like material from the rat spinal cord. J. Pharmacol. Exp. Ther. 238:1986;360-366.
6. Broadbent J., Gaspard T., Dworkin S. Assessment of the discriminative stimulus effects of cocaine in the rat: Lack of interaction with opioids. Pharmacol. Biochem. Behav. 51:1995;379-385.
7. Brown E.E., Finlay J.M., Wong J.T.F., Damsa G., Fibiger H.C. Behavioral and neurochemical interactions between cocaine and buprenorphine: Implications for the pharmacotherapy of cocaine abuse. J. Pharmacol. Exp. Ther. 256:1991;119-126.
8. Callahan P., Appel J., Cunningham K. Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology. 103:1991;50-55.
9. Callahan P., Bryan S., Cunningham K. Discriminative stimulus effects of cocaine: Antagonism by dopamine D1 receptor blockade in the amygdala. Pharmacol. Biochem. Behav. 51:1995;759-766.
10. Chipkin R.E., Berger J.G., Billard W., Iorio L.C., Chapman R., Barnett E. Pharmacology of SCH34826, on orally active enkephalinase inhibitor analgesic. J. Pharmacol. Exp. Ther. 245:1988;829-838.
11. Cunningham K., Callahan P. Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology. 104:1991;177-180.
12. Di Chiara G., Imperato A. Opposite effects of μ and κ opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1079.
13. Dykstra L., Doty P., Johnson A., Picker M. Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone. Drug Alcohol Depend. 30:1992;227-234.
14. Evans E., Wenger G. The effects of cocaine in combination with other durgs of abuse on schedule-controlled behavior in the pigeon. Pharmacol. Biochem. Behav. 37:1990;349-357.
15. Garrett E.R., Gurkan T. Pharmacokinetics of morphine and its surrogates iv: Pharmacokinetics of heroin and its derived metabolites in dogs. J. Pharm. Sci. 69:1980;1116-1134.
16. Glick S., Maisonneuve I., Raucci J., Archer S. κ-Opioid inhibition of morphine and cocaine self-administration in rats. Brain Res. 681:1995;147-152.
17. Heidbreder Ch., Goldberg S., Shippenberg T. The κ-opioid receptor agonist U69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res. 616:1993;335-338.
18. Heidbreder C.H., Babovic-Vuksanovic D., Shoaib M., Shippenberg T. Development of behavioral sensitization to cocaine: Influence of kappa opioid receptor agonists. J. Pharmacol. Exp. Ther. 275:1995;150-163.
19. Hernandez L.L., Holohean A.M., Appel J.B. Effects of opiates on the discriminative stimulus properties of dopamine agonists. Pharmacol. Biochem. Behav. 9:1978;459-463.
20. Hubner C.B., Bain G.T., Kornetsky C. The combined effects of morphine and d-amphetamine on the threshold for brain stimulation reward. Pharmacol. Biochem. Behav. 28:1987;311-315.
21. Hunt D.R., Lipton D.S., Goldsmith S., Strug D.L. Street pharmacology: Uses of heroin and cocaine in the treatment of addiction. Drug Alcohol Depend. 13:1984;375-387.
22. Jasinski D., Preston K. Evaluation of mixtures of morphine and d-amphetamine for subjective and physiological effects. Drug Alcohol Depend. 17:1986;1-13.
23. Kamien J.B., Woolverton W.L. A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys. J. Pharmacol. Exp. Ther. 248:1989;938-946.
24. Kimmel H.L., Holtzman S.G. Mu opioid agonists potentiate amphetamine- and cocaine-induced rotational behavior in the rat. J. Pharmacol. Exp. Ther. 282:1997;734-746.
25. Koob, G.F., Vaccarino, F.J., Amalric, M., Bloom, F.E., 1987. Positive reinforcement properties of drugs: Search for neural substrate. In: Engel, J., Oreland, L. (Eds.), Brain Reward Systems and Abuse, Raven Press, New York, pp. 35-50.
26. Lord J.A.H., Waterfield A.A., Hughes J., Kosterlitz H.W. Endogenous opioid peptides: Multiple agonists and receptors. Nature (London). 267:1977;495-499.
27. Lukas S.E., Mello N.K., Drieze J.M., Mendelson J.H. Buprenorphine-induced alterations of cocaine's reinforcing effects in rhesus monkey: A dose-response analysis. Drug and Alcohol Depend. 407-98:1995;87-98.
28. Magnan J., Paterson S.J, Tavani A., Kosterlitz H.W. The binding pectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmeideberg's Arch. Pharmacol. 319:1983;197-205.
29. Mansour A., Khachaturian H., Lewis M., Akil H., Watson S. Anatomy of CNS opioid receptors. Trends Neurosci. 11:1988;308-315.
30. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
31. Masukawa Y., Suzuki T., Misawa M. Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines. Psychopharmacology. 111:1993;139-143.
32. McKenna M.L., Ho B.T. The role of dopamine in the discriminative stimulus properties of cocaine. Neuropharmacology. 19:1979;297-303.
33. Mello N.K., Mendelson J.H., Bree M.P., Lukas S.E. Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science. 245:1989;859-862.
34. Mosberg H.I., Hurst R., Hruby V.J., Gee K., Yamamura H.I., Galligan J.J., Burks T.F. Bis-penicillamine enkephalins possess highly improved specificity toward δ-opioid receptors. Proc. Natl. Acad. Sci. USA. 80:1983;5871-5874.
35. Negus S., Mello N., Portoghese P., Lukas S., Mendelson J. Role of delta opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 273:1995;1245-1256.
36. Neilsen E.B., Scheel-Kruger J. Cueing effects of amphetamine and LSD elicitation by direct microinjection of the drugs into the nucleus accumbens. Eur. J. Pharmacol. 125:1986;85-92.
37. Nencini P., Woolverton W. Effects of nimodipine on the discriminative stimulus properties of d-amphetamine in rats. Psychopharmacology. 96:1988;40-44.
38. North R.A., Williams J.T. How do opiates inhibit neurotransmitter release? Trends Neurosci. 6:1983;337-339.
39. Overton D.A., Batta S.K. Investigation of narcotics and antitussives using drug discrimination techniques. J. Pharmacol. Exp. Ther. 211:1979;401-408.
40. Pepper C.M., Henderson G. Opiates and opioid peptides hyperpolarize locus coeruleus neurons in vitro. Science. 209:1980;394-396.
41. Schechter M. Lack of blockade of central dopaminergic receptors by narcotics: Comparison with chlorpromazine. Eur. J. Pharmacol. 49:1978;279-284.
42. Shippenberg T., LeFebour A., Heidbreder Ch. κ-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. J. Pharmacol. Exp. Ther. 276:1996;545-554.
43. Snoddy A.M., Tessel R.E. Nisoxetine and amphetamine share discriminative stimulus properties in mice. Pharmacol. Biochem. Behav. 19:1983;205-210.
44. Spanagel R., Herz A., Shippenberg T. The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study. J. Neurochem. 55:1990;1734-1740.
45. Spealman R. Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J. Pharmacol. Exp. Ther. 275:1995;53-62.
46. Spealman R., Bergman J. Modulation of the discriminative stimulus effects of cocaine by μ- and κ-opioids. J. Pharmacol. Exp. Ther. 261:1992;607-615.
47. Spealman R., Bergman J. Opioid modulation of the discriminative stimulus effects of cocaine: Comparison of μ-, κ- and δ-agonists in squirrel monkeys discriminating low doses of cocaine. Behav. Pharmacol. 5:1994;21-31.
48. Suzuki T., Mori T., Tsuji M., Misawa M. Interaction between discriminative stimulus effects of cocaine and morphine. Jpn. J. Pharmacol. 67:1995;341-347.
49. Taylor D., Ho B.T. Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine. Res. Commun. Chem. Pathol. Pharmacol. 21:1978;67-75.
50. Terry P., Witkin J.M., Katz J.L. Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J. Pharmacol. Exp. Ther. 270:1994;1041-1048.
51. Thierry A.M., Tassin J.P., Blanc G., Glowinski J. Selective activation of the mesocortical dopamine system by stress. Nature. 263:1976;242-243.
52. Ukai M., Mori E., Kameyama T. Cocaine-like discriminative stimulus properties of the delta-selective opioid receptor agonists, [D-Pen2, L- Pen5]enkephalin, in the rat. Eur. J. Pharmacol. 231:1993;143-144.
53. Walker E.A., Young A.M. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine. J. Pharmacol. Exp. Ther. 267:1993;322-330.
54. Wenger G., Wright D. Behavioral effects of cocaine and its interaction with d-amphetamine and morphine in rats. Pharmacol. Biochem. Behav. 35:1990;595-600.
55. Wood D.M., Emmett-Oglesby M.W. Mediation in the nucleus accumbens of the discriminative stimulus produced by cocaine. Pharmacol. Biochem. Behav. 33:1989;357-453.
56. Woolfolk D.R., Holtzman S.G. The effects of opioid receptor antagonism on the discriminative stimulus effects of cocaine and d-amphetamine in the rat. Behav. Pharmacol. 7:1996;779-787.